CY2362B1 - Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis. - Google Patents

Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis.

Info

Publication number: CY2362B1
Authority: CY; Cyprus
Prior art keywords: pyridone; hydroxy; treatment; seborrheic dermatitis; seborrheic
Prior art date: 1996-09-27

Application number

CY0300044A

Other languages

English (en)

Inventor

Manfred Bohn

Karl Theodor Kraemer

Astrid Markus

Original Assignee

Aventis Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-09-27

Filing date

2003-05-26

Publication date

2004-06-04

2003-05-26 Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh

2004-06-04 Publication of CY2362B1 publication Critical patent/CY2362B1/xx

Links

SNUSZUYTMHKCPM-UHFFFAOYSA-N 1-hydroxypyridin-2-one Chemical compound ON1C=CC=CC1=O SNUSZUYTMHKCPM-UHFFFAOYSA-N 0.000 title 1
206010039793 Seborrhoeic dermatitis Diseases 0.000 title 1
208000008742 seborrheic dermatitis Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Birds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Pyridine Compounds (AREA)

CY0300044A 1996-09-27 2003-05-26 Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis. CY2362B1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19639818A DE19639818A1 (de)	1996-09-27	1996-09-27	Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung der Seborrhoischen Dermatitis

Publications (1)

Publication Number	Publication Date
CY2362B1 true CY2362B1 (en)	2004-06-04

Family

ID=7807118

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CY0300044A CY2362B1 (en)	1996-09-27	2003-05-26	Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis.

Country Status (31)

Country	Link
EP (1)	EP0928183B1 (fr)
JP (2)	JP2001500884A (fr)
KR (1)	KR100494207B1 (fr)
CN (1)	CN1104231C (fr)
AR (1)	AR008860A1 (fr)
AT (1)	ATE209891T1 (fr)
AU (1)	AU716208B2 (fr)
BG (1)	BG64365B1 (fr)
BR (1)	BR9711575A (fr)
CA (1)	CA2267165C (fr)
CY (1)	CY2362B1 (fr)
CZ (1)	CZ291485B6 (fr)
DE (2)	DE19639818A1 (fr)
DK (1)	DK0928183T3 (fr)
ES (1)	ES2167721T3 (fr)
HU (1)	HU226955B1 (fr)
ID (1)	ID21874A (fr)
IL (1)	IL129141A0 (fr)
MA (1)	MA24333A1 (fr)
MY (1)	MY125674A (fr)
NO (1)	NO312492B1 (fr)
NZ (1)	NZ334850A (fr)
OA (1)	OA11028A (fr)
PL (1)	PL188033B1 (fr)
PT (1)	PT928183E (fr)
RS (1)	RS49801B (fr)
TR (1)	TR199900662T2 (fr)
TW (1)	TW519491B (fr)
UA (1)	UA57754C2 (fr)
WO (1)	WO1998013009A2 (fr)
ZA (1)	ZA978640B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19639816A1 (de)	1996-09-27	1998-04-02	Hoechst Ag	Antimykotische Mittel mit hoher Wirkstofffreisetzung
US20040039030A1 (en)	1996-09-27	2004-02-26	Hoechst Akeengesellschaft	Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
US20050095215A1 (en) *	2003-11-03	2005-05-05	Popp Karl F.	Antimicrobial shampoo compositions
EP2197440B1 (fr)	2007-08-31	2012-12-26	Janssen Pharmaceutica, N.V.	Combinaisons d'imazalil et d'hydroxypyridones
EP2224814A2 (fr)	2007-11-30	2010-09-08	Janssen Pharmaceutica, N.V.	Combinaisons d' azoles fongicides et de composés de pyrion
CA2711762C (fr)	2008-02-06	2016-11-01	Jan Pieter Hendrik Bosselaers	Combinaisons de phenylpyrroles et de composes pyrion
EP2587920B1 (fr)	2010-07-01	2016-08-10	Janssen Pharmaceutica, N.V.	Combinaisons antimicrobiennes des composes de pyrion avec des polyéthylèneimines
RS54766B1 (sr) *	2010-12-02	2016-10-31	Univ Kansas	Prolekovi 6-cikloheksil-1-hidroksi-4-metilpiridin-2(1h)-ona i njegovih derivata
CN103687582B (zh) *	2011-07-19	2016-03-30	露珍细胞再生株式会社	含有从酵母菌中提取出的多聚磷酸、多聚磷酸的盐或多聚磷酸的溶剂化物的多聚磷酸组合物及其制作方法
FR2983858B1 (fr) *	2011-12-08	2014-01-03	Fabre Pierre Dermo Cosmetique	Nouveaux composes inhibiteurs de la lipogenese
CN104744359B (zh) *	2015-03-06	2017-10-10	上药康丽（常州）药业有限公司	一种环吡酮的精制方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2234009C3 (de) *	1972-07-11	1979-01-11	Hoechst Ag, 6000 Frankfurt	Kosmetische Zubereitungen
NL8601762A (nl) *	1986-07-07	1988-02-01	Bouke Jan Lange	Werkwijze voor de reiniging en conditionering en eventuele medicinale behandeling van het haar en de hoofdhuid, een voor dit doel bruikbare tweefasen shampoo, alsmede een verpakking daarvoor.
BR9307019A (pt) *	1992-09-08	1999-02-23	Procter & Gamble	Composição de shampoo substancialmente incolor suave
DE4333893A1 (de) *	1993-10-05	1995-04-06	Hoechst Ag	Kosmetische Zubereitungen
FR2722689B1 (fr) *	1994-07-20	1996-10-04	Fabre Pierre Dermo Cosmetique	Nouveau produit de combinaison comprenant un agent antifongique et du crotamiton comme potentialisateur de l'activite de l'agent antifongique, et compositions dermatologiques et/ou cosmetiques le comprenant

1996
- 1996-09-27 DE DE19639818A patent/DE19639818A1/de not_active Withdrawn
1997
- 1997-09-16 CA CA002267165A patent/CA2267165C/fr not_active Expired - Lifetime
- 1997-09-16 ES ES97910294T patent/ES2167721T3/es not_active Expired - Lifetime
- 1997-09-16 WO PCT/EP1997/005070 patent/WO1998013009A2/fr not_active Ceased
- 1997-09-16 BR BR9711575A patent/BR9711575A/pt not_active Application Discontinuation
- 1997-09-16 KR KR10-1999-7002553A patent/KR100494207B1/ko not_active Expired - Lifetime
- 1997-09-16 AT AT97910294T patent/ATE209891T1/de active
- 1997-09-16 DE DE59705697T patent/DE59705697D1/de not_active Expired - Lifetime
- 1997-09-16 TR TR1999/00662T patent/TR199900662T2/xx unknown
- 1997-09-16 DK DK97910294T patent/DK0928183T3/da active
- 1997-09-16 IL IL12914197A patent/IL129141A0/xx not_active IP Right Cessation
- 1997-09-16 AU AU47746/97A patent/AU716208B2/en not_active Expired
- 1997-09-16 UA UA99042351A patent/UA57754C2/uk unknown
- 1997-09-16 EP EP97910294A patent/EP0928183B1/fr not_active Expired - Lifetime
- 1997-09-16 NZ NZ334850A patent/NZ334850A/en not_active IP Right Cessation
- 1997-09-16 ID IDW990129A patent/ID21874A/id unknown
- 1997-09-16 PT PT97910294T patent/PT928183E/pt unknown
- 1997-09-16 CZ CZ19991075A patent/CZ291485B6/cs not_active IP Right Cessation
- 1997-09-16 JP JP10515223A patent/JP2001500884A/ja active Pending
- 1997-09-16 PL PL33260397A patent/PL188033B1/pl unknown
- 1997-09-16 CN CN97198266A patent/CN1104231C/zh not_active Expired - Lifetime
- 1997-09-16 HU HU9903811A patent/HU226955B1/hu unknown
- 1997-09-16 RS YUP-134/99A patent/RS49801B/sr unknown
- 1997-09-25 AR ARP970104432A patent/AR008860A1/es not_active Application Discontinuation
- 1997-09-25 TW TW086113944A patent/TW519491B/zh not_active IP Right Cessation
- 1997-09-26 MY MYPI97004501A patent/MY125674A/en unknown
- 1997-09-26 ZA ZA9708640A patent/ZA978640B/xx unknown
- 1997-09-29 MA MA24814A patent/MA24333A1/fr unknown
1999
- 1999-03-17 BG BG103260A patent/BG64365B1/bg unknown
- 1999-03-25 NO NO19991460A patent/NO312492B1/no not_active IP Right Cessation
- 1999-03-26 OA OA9900071A patent/OA11028A/fr unknown
2003
- 2003-05-26 CY CY0300044A patent/CY2362B1/xx unknown
2006
- 2006-03-22 JP JP2006078057A patent/JP2006176540A/ja not_active Abandoned

Also Published As

Publication number	Publication date
BR9711575A (pt)	1999-08-24
NO312492B1 (no)	2002-05-21
ATE209891T1 (de)	2001-12-15
CN1231595A (zh)	1999-10-13
EP0928183B1 (fr)	2001-12-05
KR100494207B1 (ko)	2005-06-13
HUP9903811A1 (hu)	2000-04-28
BG64365B1 (bg)	2004-12-30
CZ107599A3 (cs)	1999-06-16
AU716208B2 (en)	2000-02-24
ZA978640B (en)	1998-03-27
MY125674A (en)	2006-08-30
YU13499A (sh)	2001-09-28
OA11028A (fr)	2003-03-06
CZ291485B6 (cs)	2003-03-12
JP2006176540A (ja)	2006-07-06
HK1022267A1 (en)	2000-08-04
KR20000048613A (ko)	2000-07-25
ID21874A (id)	1999-08-05
CA2267165C (fr)	2003-12-16
PL188033B1 (pl)	2004-11-30
DE19639818A1 (de)	1998-04-02
NO991460L (no)	1999-03-25
AR008860A1 (es)	2000-02-23
PT928183E (pt)	2002-05-31
PL332603A1 (en)	1999-09-27
HU226955B1 (en)	2010-03-29
JP2001500884A (ja)	2001-01-23
UA57754C2 (uk)	2003-07-15
HUP9903811A3 (en)	2001-11-28
CN1104231C (zh)	2003-04-02
RS49801B (sr)	2008-06-05
WO1998013009A2 (fr)	1998-04-02
NO991460D0 (no)	1999-03-25
CA2267165A1 (fr)	1998-04-02
MA24333A1 (fr)	1998-04-01
NZ334850A (en)	2001-02-23
TR199900662T2 (xx)	1999-06-21
TW519491B (en)	2003-02-01
IL129141A0 (en)	2000-02-17
WO1998013009A3 (fr)	1998-05-14
DE59705697D1 (de)	2002-01-17
AU4774697A (en)	1998-04-17
BG103260A (en)	2000-01-31
EP0928183A2 (fr)	1999-07-14
ES2167721T3 (es)	2002-05-16
DK0928183T3 (da)	2002-04-02

Publication	Publication Date	Title
ZA993364B (en)	2000-12-01	Novel 4-phenylpiperidines for the treatment of pruritic dermatoses.
ZA97631B (en)	1997-08-04	Migraine treatment.
ZA971038B (en)	1997-09-09	Process for the partial oxidation of alkanes.
ZA976696B (en)	1998-02-10	Treated titanium dioxide.
AU2277501A (en)	2001-07-09	One-step system for cleansing, conditioning, and treating the skin
ZA9710322B (en)	1998-06-10	Process for the preparation of benzyl-ethers.
ZA9811507B (en)	2000-06-19	Combination effective for the treatment of impotence.
ZA984569B (en)	2000-01-28	Roll-formed bearing race and process for producing the same.
AU2825295A (en)	1996-01-05	Method for the treatment, prevention or minimization of hair loss
EP0672840A3 (fr)	1996-07-17	Palier lisse.
ZA200003236B (en)	2002-01-02	Combination therapy for the treatment of migraine.
CY2362B1 (en)	2004-06-04	Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis.
ZA9710114B (en)	1998-06-08	Method for the expression of genes.
MXPA03004017A (es)	2004-02-12	Metodo para el tratamiento de inflamacion.
ZA200110474B (en)	2003-03-20	Method and device for the continuous of NaAlCl4 or NaFeCl4.
ZA976350B (en)	1998-02-03	Treatment of liquid.
ZA200109607B (en)	2003-04-30	Treated closures 3.
GR950100091A (en)	1995-11-30	Method for the treatment of plants.
ZA973843B (en)	1997-11-10	Treatment of asthma with TNFR-lg.
AU3814599A (en)	1999-11-01	Use of erythropoietin for the treatment of haemochromatoses
ZA975637B (en)	1998-01-23	Method for the treatment of emesis.
ZA200109605B (en)	2003-04-30	Treated closures 2.
ZA200002338B (en)	2001-11-12	Combination therapy for the treatment of migraine.
ZA200003235B (en)	2002-01-02	Combination therapy for the treatment of migraine.
SI0928183T1 (en)	2002-06-30	Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis